Clinical trial
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy…
NCT00192335 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192335 |
|---|---|
| Title | Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants |
| Official title | A Prospective, Double-Blind, Randomized Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants Ages 5 Through 49 Years |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Biological |
| Interventions | CAIV-T, CAIVT, FluMist |
| Enrollment | 890 |
| Start date | Jul 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 27, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: